-
Donor Derived Cell Free DNA Initiates De-Novo Donor Specific Antibody (DSA) Responses
-
Donor Derived Neoplasia: Will It Be a Risk after Clinical Pig Organ Xenotransplantation?
-
Donor Derived Strongyloidiasis, a Preventable Event
-
Donor Derived Tuberculosis in Solid Organ Transplantation in the United States: 10 Years of UNOS Ad Hoc Disease Transmission Advisory Committee Experience
-
Donor Exclusions and Shifting Trends in Living Liver Donor Evaluations: A Single Center Experience
-
Donor Graft CMV Serostatus Influences the Development of Arterial and Venous Vascular Events in Seronegative Recipients after Organ Transplantation
-
Donor Hepatitis C Seropositivity Confers Poorer Post-transplant Outcomes In Recipients Of Marginal Livers In The Post-hepatitis C Treatment Era
-
Donor Insulin Therapy Predicts Better Graft Survival in Pancreas Transplantation
-
Donor Lymphocyte Chimerism and Homozygosity Are Critical Indicators for Timely and Accurate Diagnosis of Acute Graft vs. Host Disease after Liver Transplantation
-
Donor Management in Donation after Brain Death: A Window of Opportunity – Are Pro-Inflammatory Mediators the Target and What is the Effect of Duration of Brain Death?
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 214
- Next Page »